The Nordic Rectal Prolapse Study
NORDIC
1 other identifier
observational
430
1 country
1
Brief Summary
The goal of this observational study is to gather data about surgical procedures for rectal prolapse in adult human subjects. The main question it aims to answer is:
- Which procedure is best for treating external rectal prolapse? Participants will:
- be included if they can consent to participation
- be offered standard care treatment, as no interventions will be done
- be asked to answer relevant questionnaires within 3 months prior to the surgery for rectal prolapse
- be asked to answer the same questionnaires 6 and 12 months postoperative
- optionally answer the questionnaires again at 3 and 1 year postoperative, but this is not part of the existing funding body
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 4, 2022
CompletedFirst Posted
Study publicly available on registry
October 6, 2022
CompletedStudy Start
First participant enrolled
April 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2027
January 23, 2025
January 1, 2025
3.8 years
October 4, 2022
January 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of life after surgery
To determine whether well-established procedures for external rectal prolapse are non-inferior to LVMR using EQ-5D at 6 months post-surgery.
6 months
Secondary Outcomes (3)
Constipation
12 months
Faecal incontinence
6 months
Complications
6 months
Eligibility Criteria
All adult patients getting surgery for external rectal prolapse.
You may qualify if:
- undergoing surgery for rectal prolapse
You may not qualify if:
- unable to consent to participating
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aarhus University Hospitallead
- Novo Nordisk A/Scollaborator
- Esbjerg Hospital - University Hospital of Southern Denmarkcollaborator
- Universitätsmedizin Mannheimcollaborator
- Odense University Hospitalcollaborator
- Hillerod Hospital, Denmarkcollaborator
- Groene Hart Ziekenhuiscollaborator
- ASZ Aalstcollaborator
Study Sites (1)
Aarhus University Hospital
Aarhus N, 8200, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Christensen, Prof., MDSc
Aarhus University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ph.D. student
Study Record Dates
First Submitted
October 4, 2022
First Posted
October 6, 2022
Study Start
April 1, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
May 31, 2027
Last Updated
January 23, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share